The trademark PROTEGA was filed by Verici Dx Plc, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on July 18, 2021, and received one opposition filed on October 18, 2021 by Promega Corporation on (a) Art. 8(4), (b) Likelihood of confusion, (c) Unfair advantage and detriment to distinctiveness or repute. the opponent was represented by De Justo, Mario and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 18, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with Medical diagnostic blood or biopsy testing assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection and all of the goods related to the field of organ transplants..
The mark was filed in class 10 with Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients and all of the goods related to the field of organ transplants..
The mark was filed in class 42 with following description of goods:
Development of new technology for others in the field of medical devices and medical diagnostic apparatuses
Research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence
Laboratory research in the field of kidney transplant
Medical research services
Computer software development
Providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis
All of the services related to the field of organ transplants.
The mark was filed in class 44 with following description of goods:
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms
Medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients
All of the services related to the field of organ transplants.